Table 4.
No. | Cost of primary treatment ($)a),b) | p-value | Net medical cost ($)b),c) | p-value | 5-Year OS (%) | 5-Year DSS (%) | |
---|---|---|---|---|---|---|---|
Sex | |||||||
Male | 1,227 | 8,713±216 | 0.339 | 16,097±406 | 0.458 | 65.8 | 71.1 |
Female | 592 | 8,351±309 | 15,572±574 | 68.2 | 71.3 | ||
Age (yr) | |||||||
20-49 | 386 | 7,941±294 | 0.263 | 16,175±678 | 0.026 | 72.3 | 72.5 |
50-59 | 459 | 8,730±346 | 16,980±709 | 72.7 | 75.6 | ||
60-69 | 581 | 8,688±321 | 16,146±638 | 65.8 | 71.2 | ||
70-89 | 392 | 8,946±445 | 14,117±570 | 54.7 | 64.2 | ||
Surgery type | |||||||
TG | 517 | 11,513±398 | < 0.001 | 20,868±699 | < 0.001 | 48.5 | 52.1 |
STG | 1,302 | 7,437±181 | 13,965±357 | 73.7 | 78.6 | ||
Charlson comorbidity index | |||||||
0-1 | 1,139 | 7,575±187 | < 0.001 | 14,787±385 | < 0.001 | 67.5 | 69.9 |
2 | 327 | 8,892±346 | 16,632±715 | 69.3 | 72.7 | ||
3 | 144 | 11,193±890 | 18,792±1,426 | 67.6 | 80.3 | ||
≥ 4 | 209 | 12,416±812 | 19,418±1,350 | 55.1 | 71.9 | ||
Income | |||||||
≤ 20 percentile | 277 | 8,621±438 | 0.402 | 14,731±763 | 0.040 | 64.7 | 68.3 |
21-80 percentile | 995 | 8,398±217 | 15,600±429 | 68.4 | 73.1 | ||
≥ 81 percentile | 547 | 8,940±375 | 17,125±674 | 64.1 | 69.1 | ||
Health insurance type | |||||||
NHI | 1,761 | 8,591±181 | 0.893 | 16,029±339 | 0.089 | 67.1 | 71.8 |
Medical aid | 58 | 8,727±766 | 12,814±1,421 | 48.5 | 48.5 | ||
Residential area | |||||||
Metropolitan | 859 | 8,687±283 | 0.622 | 16,089±479 | 0.643 | 66.9 | 71.7 |
Non-metropolitan | 960 | 8,513±219 | 15,781±459 | 66.2 | 70.7 | ||
Hospital location | |||||||
Metropolitan | 1,594 | 8,575±194 | 0.697 | 15,770±344 | 0.207 | 66.9 | 71.5 |
Nonmetropolitan | 225 | 8,742±382 | 17,045±1,120 | 63.9 | 68.4 | ||
Hospital volume (beds) | |||||||
< 1,000 | 765 | 8,892±256 | 0.017 | 14,172±507 | 0.034 | 64.6 | 69.6 |
1,000-1,999 | 707 | 7,978±260 | 13,978±519 | 71.2 | 75.1 | ||
≥ 2,000 | 347 | 9,201±506 | 15,111±801 | 61.4 | 66.4 | ||
Disabled status | |||||||
No | 1,654 | 8,422±172 | 0.041 | 15,858±346 | 0.511 | 66.9 | 71.1 |
Yes | 165 | 10,327±908 | 16,617±1,146 | 62.9 | 71.5 | ||
RT use | |||||||
No | 1,741 | 8,441±180 | < 0.001 | 15,642±337 | < 0.001 | 67.1 | 71.4 |
Yes | 78 | 12,175±792 | 22,526±1,623 | 58.0 | 68.7 | ||
Death during study | |||||||
Yes | 607 | 11,234±422 | < 0.001 | 24,160±701 | < 0.001 | - | - |
No | 1,212 | 7,274±147 | 11,804±288 | - | - |
OS, overall survival; DSS, disease-specific survival; TG, total gastrectomy; STG, subtotal gastrectomy; NHI, National Health Insurance; RT, radiotherapy.
Defined as medical bill expenses claimed by medical service providers for primary treatment,
All costs are presented in U.S. dollars, with an exchange rate of 1,103 Korean won to 1 U.S. dollar, which was the annual exchange rate in 2008,
Defined as medical bill expenses claimed by medical service providers from diagnosis to death or last follow-up.